Arkolith/Insider Trading/MYMD/Form 4

Rivard Paul

EVP of Operations, GCMyMD Pharmaceuticals, Inc. (MYMD) · full profile →Form 4 · filed Dec 8, 2022
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2022Buy(P)10K$1.53$15K225K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-034969) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML